Made-at-McMaster inhaled COVID-19 vaccine begins Phase 2 human clinical trial
While confidence in mRNA vaccines for COVID-19 has reached an all-time low, the pharmaceutical and research lobbies are looking for new ways to reach the population – even through the….










